PneumoWave Raises £7.5M in Series A Funding

PneumoWave, a Glasgow, Scotland, UK-based digital well being firm, raised £7.5M in Series A funding.

The spherical was led by Scottish National Investment Bank, Scottish Enterprise, IIG, Equity Gap, Alba Equity, and Mark Bamforth of Thairm Bio.

The firm intends to make use of the funds to allow scientific validation and regulatory submission of its platform.

Led by CEO Dr Bruce Henderson, PneumoWave is advancing a biosensor know-how platform for distant wi-fi diagnosing and monitoring probably deadly respiratory adjustments in high-risk affected person teams. A wearable biosensor alerts carers and emergency medical providers. The firm goals to cut back the devastating socioeconomic affect of drug overdose, now the main reason behind unintended dying in most developed nations.

PneumoWave’s know-how is being developed as a part of a global analysis program in collaboration with the University of Dundee, University of Glasgow, King’s College London, and NRCH and Department of Health in Victoria, Australia.



Leave a Comment